Drug interactions
Cisplatin + Sipuleucel-t
Severity: Moderate
Cisplatin and Sipuleucel-t: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T depends on the patient's own immune cells to generate an anti-tumor response. Cisplatin-induced myelosuppression and immunosuppression may blunt that response.
What this interaction means in plain words
Cisplatin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Cytotoxic immunosuppression by cisplatin may impair immune cell activation by sipuleucel-T.
What to do
Avoid concurrent immunosuppressive chemotherapy around leukapheresis and infusion where possible. Review sequencing with the oncology team.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cisplatin and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Cisplatin
- Cidofovir + Cisplatin Contraindicated
- Adefovir + Cisplatin Major
- Adenovirus types 4 and 7 live + Cisplatin Major
- Amikacin + Cisplatin Major
- Amphotericin b deoxycholate + Cisplatin Major
- Amphotericin b + Cisplatin Major
Frequently asked questions
Can I take Cisplatin with Sipuleucel-t?
MediHelp rates the interaction as moderate. Cisplatin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T depends on the patient's own immune cells to generate an anti-tumor response. Cisplatin-induced myelosuppression and immunosuppression may blunt that response.
How serious is the interaction between Cisplatin and Sipuleucel-t?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent immunosuppressive chemotherapy around leukapheresis and infusion where possible. Review sequencing with the oncology team.
What other medicines interact with Cisplatin?
MediHelp also lists interactions of Cisplatin with, for example, Cidofovir, Adefovir, Adenovirus types 4 and 7 live. The full list is on the Cisplatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
